Optimind Pharma Corp. (CNSX: OMND)
Health Care · Health Care Providers & Services · CA
CA$—
— today · — 1Y
Optimind Pharma Corp. (CNSX: OMND) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $372.80K.
trading between 0.01 and 0.01.
Tweenvest scores Optimind Pharma Corp. across four factors: quality 16/100, value 68/100. Its strongest factor is value.
OMND price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $372.80K
- Revenue (TTM)
- $88.95K
- P/E
- —
- EPS
- -0.00
- Dividend yield
- —
- Beta (5Y)
- 0.14
- 52-week high
- CA$0.01
- 52-week low
- CA$0.01
- Avg volume (3M)
- —
- Shares outstanding
- 103.15M
- Employees
- —
- Next earnings
- —
About Optimind Pharma Corp.
Optimind Pharma Corp. is a Canadian pharmaceutical enterprise headquartered in Toronto. The company specializes in offering psychedelic-based therapies, including ketamine-assisted treatment and other advanced psychedelic-enhanced psychotherapy modalities, targeting mental health conditions such as post-traumatic stress syndrome, anxiety, depression, and various other psychological disabilities. Additionally, Optimind Pharma operates a dedicated clinic that provides patients with medical cannabis and a range of alternative medical treatments, notably featuring ketamine-enhanced psychotherapy as part of its offerings.
- ISIN
- CA68405U1012
- Listed since
- Aug 4, 2022
- Exchange
- Canadian National Stock Exchange
- Currency
- CAD
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| UnitedHealth Group IncorporatedNYSE: UNH | $350.16B | $398.76 | +2.22% |
| CVS Health CorporationNYSE: CVS | $118.97B | $94.11 | +1.17% |
| McKesson CorporationNYSE: MCK | $100.14B | $873.79 | +1.73% |
| HCA Healthcare, Inc.NYSE: HCA | $92.92B | $429.24 | +0.01% |
| Elevance Health, Inc.NYSE: ELV | $86.86B | $402.63 | +0.52% |
| The Cigna GroupNYSE: CI | $73.33B | $280.45 | +1.06% |
| Cencora, Inc.NYSE: COR | $60.69B | $323.77 | +1.80% |
| Cardinal Health, Inc.NYSE: CAH | $53.38B | $232.37 | +1.25% |
Figures last refreshed Aug 18, 2026.